Men develop cancer more often than women at the majority of organ sites, and that disparity is only partly explained by lifestyle choices like smoking and drinking. A large study tracking nearly 300,000 adults found that men had a 1.3- to 10.8-times higher incidence than women across most of the 21 cancer sites examined, with behavioral and environmental differences accounting for only a modest share of that gap. Some cancers affect organs unique to male anatomy, while others simply hit men harder for reasons that are still being untangled. Understanding which cancers pose the greatest threat, what the warning signs look like, and when screening makes sense can make a real difference in catching disease early.
Why Men Get More Cancers Than Women
The sex gap in cancer incidence is wider than most people realize. In the NIH-AARP Diet and Health study, which followed over 170,000 men and 120,000 women aged 50 to 71 for up to 16 years, men developed roughly twice as many new cancers overall. The gap was most extreme for esophageal cancer, where men faced a risk nearly 11 times higher, followed by cancers of the larynx and stomach, each about 3.5 times more common in men. Only thyroid and gallbladder cancers were more common in women. Adjusting for smoking, alcohol, body mass, diet, and occupational exposures narrowed the gap somewhat but never closed it. Risk factors explained just 11% of the male excess for esophageal cancer and topped out at about 50% for lung cancer.1PubMed Central. Sex disparities in the incidence of 21 cancer types: Quantification of the contribution of risk factors
Something biological is clearly at work. One leading hypothesis involves the Y chromosome itself. As men age, a growing fraction of their white blood cells lose the Y chromosome entirely, a phenomenon called mosaic loss of Y (LOY). An analysis of over 200,000 men in the UK Biobank estimated that roughly 20% had detectable LOY, and the genetic determinants of this loss overlap heavily with genes involved in cell-cycle regulation and cancer susceptibility.2Nature. Genetic predisposition to mosaic Y chromosome loss in blood Earlier work in a smaller cohort of elderly men found that those with LOY had roughly twice the risk of dying from any cause and more than three times the risk of dying from a non-blood-related cancer compared to men whose Y chromosomes remained intact.3Nature Genetics. Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer The Y chromosome, in other words, appears to do more than determine sex. Losing it in immune cells may weaken the body’s ability to detect and destroy tumors.
Hormones also play a role, though not a simple one. Androgen receptor activity appears to promote tumor growth in cancers of the esophagus, bladder, head and neck, and stomach, and is associated with poorer survival in those diseases. For other cancers, including melanoma and kidney cancer, the relationship between testosterone and tumor biology is less clear-cut.4PubMed Central. Testosterone and Androgen Receptor in Cancers with Significant Sex Dimorphism in Incidence Rates and Survival
Prostate Cancer
Prostate cancer is the most common non-skin cancer in men and the one with the most complicated screening debate. Your risk rises sharply with age, and family history matters a great deal. Men with a first-degree relative who had prostate cancer face about a 68% higher risk of developing it themselves, and a 72% higher risk of the lethal form. Even a family history of breast cancer in female relatives raises prostate cancer risk by about 21%.5PubMed Central. Family history of breast or prostate cancer and prostate cancer risk
Inherited gene mutations push risk much higher. BRCA2 carriers face about a four-and-a-half-fold increase in prostate cancer risk over the general population, with an estimated 60% chance of developing the disease by age 85. BRCA1 carriers also have elevated risk, roughly two-and-a-half times the population rate, with the excess concentrated before age 65.6European Urology. Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study Beyond the BRCA genes, mutations in MSH2 and HOXB13 also confer notably elevated risk.7PubMed. A systematic review of family history, race/ethnicity, and genetic risk on prostate cancer detection and outcomes: Considerations in PSA-based screening Black men have higher prostate cancer incidence, driven largely by environmental and socioeconomic factors though genetic differences may contribute, while Asian men have lower incidence.
The prostate-specific antigen (PSA) blood test can detect prostate cancer early, but whether that translates into lives saved is genuinely contested. A large systematic review and meta-analysis found that PSA screening probably has no effect on overall mortality and may reduce prostate-cancer-specific deaths by roughly one per 1,000 men screened over ten years.8PubMed. Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis The European ERSPC trial, which showed the strongest screening benefit, still found that 37 additional men needed to be diagnosed for every one prostate cancer death prevented.9JAMA. Screening for Prostate Cancer With the Prostate-Specific Antigen Test: A Review of Current Evidence The concern is overdiagnosis: finding slow-growing tumors that would never have caused symptoms, then subjecting men to biopsies and treatments that carry real harms, including urinary incontinence and erectile dysfunction. Most guidelines now recommend that men aged 55 to 69 have an informed conversation with their doctor about the trade-offs rather than simply getting screened automatically.10PubMed Central. Prostate cancer screening—when to start and how to screen?
Testicular Cancer
Testicular cancer is the most common cancer in young men, typically striking between ages 15 and 35. Unlike most other cancers, it has a high cure rate even when caught at later stages, but earlier detection still matters. A study of diagnosis delays found that each additional day of delay correlated with a measurable increase in tumor size and higher rates of lymph node involvement and elevated tumor markers.11Actas Urológicas Españolas (English Edition). The effect of diagnosis delay in testis cancer on tumor size, tumor stage and tumor markers
The strongest known risk factors are a history of undescended testicle (cryptorchidism), a previous testicular cancer in the other testicle, and a family history of the disease.12Nature Reviews Urology. Adolescent and adult risk factors for testicular cancer The typical warning sign is a painless lump or swelling in one testicle, sometimes accompanied by a dull ache in the groin or lower abdomen. Monthly self-examination is simple and free, and interventions promoting testicular self-examination, from educational videos to awareness campaigns, have consistently increased men’s knowledge and intentions to check themselves.13Cancer Nursing. Promoting Testicular Cancer Awareness and Screening
Penile Cancer
Penile cancer is rare but often diagnosed late because men avoid seeking help for genital symptoms, and early lesions can be mistaken for benign skin conditions. About 95% of cases are squamous cell carcinoma, and its subtypes vary in how aggressively they behave.14PubMed Central. The Diagnosis and Treatment of Penile Cancer A persistent sore, thickening, or color change on the penis that does not resolve within a few weeks warrants a biopsy. Early-stage penile cancer is curable, but outcomes deteriorate quickly if the cancer spreads to the inguinal lymph nodes.
Roughly 40% of penile tumors are linked to human papillomavirus (HPV) infection.15PubMed Central. HPV and Penile Cancer: Epidemiology, Risk Factors, and Clinical Insights The non-HPV pathway involves chronic inflammation, most often from phimosis (a tight foreskin that cannot be retracted) or lichen sclerosus.16Nature Reviews Disease Primers. Penile cancer Other risk factors include smoking, immunosuppression, and poor genital hygiene. Circumcision appears protective, reducing the risk by roughly two-thirds.14PubMed Central. The Diagnosis and Treatment of Penile Cancer Prevention strategies also include limiting HPV infection through vaccination or condom use, treating chronic inflammatory conditions, and smoking cessation.17PubMed. Penile cancer: epidemiology, pathogenesis and prevention
Male Breast Cancer
Men can and do get breast cancer, though it accounts for less than 1% of all breast cancer diagnoses. That rarity is part of the problem: most men have no idea they are at risk, which leads to long delays in seeking help. In one study of male breast cancer patients, the average time from first symptoms to a doctor visit was over 12 months.18PubMed Central. Delayed presentation, diagnosis, and psychosocial aspects of male breast cancer By the time these men were diagnosed, roughly two-thirds were node-positive, meaning the cancer had already spread to nearby lymph nodes. A separate retrospective analysis found that nearly half of male breast cancer patients presented at Stage II, and five-year overall survival was about 63%.19PubMed Central. Characteristics, Treatment, and Survival of Male Breast Cancer: A 21-year Retrospective Analysis at a Community Academic Institute in Central Illinois
The major risk factors include advancing age, hormonal imbalances (such as those caused by obesity, liver disease, or Klinefelter syndrome), radiation exposure, and family history. The single most relevant genetic risk factor is a BRCA2 mutation.20PubMed. Male Breast Cancer: Epidemiology and Risk Factors The typical symptom is a painless lump behind or near the nipple, sometimes accompanied by nipple discharge, retraction, or skin changes. Because men have so little breast tissue, tumors tend to be close to the chest wall, which can make them easier to feel but also quicker to invade underlying structures.
Bladder and Kidney Cancer
Bladder cancer hits men three to four times more often than women.21PubMed. Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes Smoking is the single biggest modifiable risk factor, but the sex disparity persists even after controlling for tobacco exposure, pointing again to biological differences. Testosterone levels appear to correlate with bladder cancer occurrence, suggesting that androgen signaling may play a direct role.22Scientific Reports. Relationship between testosterone and male bladder cancer The hallmark symptom is blood in the urine, which is often painless and intermittent. Men who notice pink or rust-colored urine, even once, should see a doctor promptly. About three-quarters of newly diagnosed bladder cancers are non-invasive and can be treated without removing the bladder, but recurrence rates are high, requiring regular surveillance with cystoscopy.23PubMed. Epidemiology and risk factors of urothelial bladder cancer
Kidney cancer follows a similar pattern: men are about twice as likely to develop it as women and face higher death rates. Risk factors include high blood pressure, obesity, and smoking, along with possible genetic and hormonal components.24PubMed Central. Sex and Gender Differences in Kidney Cancer: Clinical and Experimental Evidence Kidney tumors often grow silently for years. When symptoms do appear, they typically include blood in the urine, flank pain, or a palpable mass. Many kidney cancers are now found incidentally on imaging done for other reasons.
Occupational and Environmental Risks
The workplace is a cancer risk factor that often goes overlooked, and it affects men disproportionately because they have historically been overrepresented in heavy industry and chemical-handling jobs. A study of Japanese men found that the longest tenure in workplaces handling hazardous chemicals was associated with elevated odds of lung cancer (about 1.8 times higher), pancreatic cancer (about twice as high), bladder cancer (about 1.4 times higher), and esophageal cancer (about 1.7 times higher). The relationship held even after accounting for smoking, though smoking amplified the effect.25PubMed Central. Length of employment in workplaces handling hazardous chemicals and risk of cancer among Japanese men
An Italian case-control study identified specific occupations with elevated lung cancer risk after adjusting for smoking: non-ferrous metal workers, painters, welders, plumbers, construction workers, and dockers all had significantly increased odds. Men exposed to known carcinogens in any occupation faced roughly twice the lung cancer risk of unexposed men, accounting for an estimated 9.5% of all male lung cancer cases in the study.26PubMed. Occupational risk factors for lung cancer in men and women: a population-based case-control study in Italy For men in these jobs, awareness of the added risk can inform decisions about protective equipment, workplace monitoring, and cancer screening conversations.
Lynch Syndrome and Prostate Cancer
Lynch syndrome, an inherited condition best known for raising the risk of colorectal and endometrial cancers, has increasingly been recognized as a risk factor for prostate cancer too. A meta-analysis found that male Lynch syndrome carriers face roughly a two- to four-fold increased risk of prostate cancer, depending on the specific mutation and study design.27PubMed. Risk of prostate cancer in Lynch syndrome: a systematic review and meta-analysis More recent data from a cohort of 235 men with Lynch syndrome found that by age 75, the cumulative incidence of any prostate cancer was 38%, with clinically significant disease reaching 26%. Men carrying MSH2 mutations appeared most likely to develop tumors that were mismatch-repair deficient, a characteristic that may respond to immunotherapy. Those with a family history of prostate cancer on top of their Lynch syndrome diagnosis were three times more likely to develop the disease.28European Urology Open Science. Prostate Cancer Risk and DNA Mismatch Repair Deficiency Among Lynch Syndrome Patients
This matters practically: if you have Lynch syndrome, or know it runs in your family, prostate cancer screening conversations with your doctor should start earlier and be more aggressive than for average-risk men.
Why Men Delay Seeking Help
One of the biggest threats to early cancer detection in men is not medical, it is behavioral. A systematic review of help-seeking delays among men identified several recurring barriers: reluctance to express concern about health symptoms, embarrassment about genital or bowel-related issues, anxiety about what a diagnosis might mean, and poor communication with healthcare providers.29PubMed. A systematic review of the factors associated with delays in medical and psychological help-seeking among men
These patterns play out vividly for specific cancers. Men with testicular cancer symptoms delayed because they did not recognize the signs, feared being perceived as weak or hypochondriacal, or were embarrassed by the anatomical location.30PubMed Central. Qualitative study of men’s perceptions of why treatment delays occur in the UK for those with testicular cancer Men later diagnosed with colorectal cancer misinterpreted rectal bleeding or changes in bowel habits as something benign, or simply could not bring themselves to discuss it.31PubMed. Help-seeking experiences of men diagnosed with colorectal cancer: a qualitative study The result is the same across cancer types: delayed diagnosis means larger tumors, later stages, and fewer treatment options.
Interventions that target men specifically show promise. A systematic review found that educational programs improve men’s knowledge of cancer risk reduction, particularly when they use multiple formats and account for differences in health literacy.32PubMed. Promoting men’s knowledge of cancer risk reduction: A systematic review of interventions Partner-mediated approaches, where a spouse or partner encourages screening, have shown particularly strong effects on actual screening uptake.33American Journal of Preventive Medicine. Improving Health Screening Uptake in Men: A Systematic Review and Meta-analysis
HPV Vaccination for Men
HPV is not just a women’s health concern. The virus drives about 40% of penile cancers, a large share of anal cancers, and a growing proportion of oropharyngeal (throat) cancers, the last of which are more common in men. Randomized trials have shown that the quadrivalent HPV vaccine produces strong antibody responses in men and is highly effective against genital warts and precancerous anal lesions.34PubMed Central. HPV vaccination in boys and men
The public health math behind vaccinating boys is nuanced and depends on how many people are already vaccinated. At lower coverage levels (under 60%), more than half the benefit of adding boys to vaccination programs comes from reducing cervical cancer in women through herd immunity. At high coverage (above 90%), almost all the additional benefit goes to preventing cancers directly in men, particularly anal and oropharyngeal cancers in men who have sex with men.35JNCI Cancer Spectrum. Who Will Benefit From Expanding HPV Vaccination Programs to Boys? Either way, vaccination protects men from cancers that have no routine screening test, making prevention the only realistic strategy.
Fertility and Sexual Health After Treatment
Cancer treatment can have lasting effects on reproductive and sexual function, an issue that many young men are not warned about until it is too late to take action. Chemotherapy, particularly with alkylating agents, testicular radiation, and surgery involving the genitourinary tract or lower spine are all risk factors for impaired sperm production, testosterone deficiency, and sexual dysfunction.36PubMed. Improving Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancer: Progress and Future Directions for Survivorship Research Advances in cancer therapy have dramatically improved survival, especially in childhood cancers, but lower overall toxicity does not automatically mean lower harm to the reproductive system.37PubMed. Impacts of cancer therapy on male fertility: Past and present
Sperm banking before treatment remains the most straightforward fertility preservation option for post-pubertal men and adolescents. For prepubertal boys, experimental techniques involving testicular tissue cryopreservation are under investigation but not yet clinically available. The window for sperm banking closes once chemotherapy or radiation begins, which is why fertility counseling needs to happen at the point of diagnosis, not after treatment starts. Sexual dysfunction after treatment, including changes in desire, erectile function, and ejaculation, also affects quality of life and relationships. These issues are treatable, but only if the patient and the clinical team are willing to discuss them openly.38PubMed Central. Fertility and sexual dysfunction in young male cancer survivors